Evolva (EVE)

Business description

Evolva is a Swiss high-tech fermentation company. It has a proprietary yeast technology platform, which it uses to create and manufacture high-value speciality molecules for nutritional and consumer products.

Stock data

Market cap.CHF246.6m
Last closeCHF0.32
High / Low (52 weeks)CHF0.7 / CHF0.3
Stock market listingSW
Forecast net debt (m)N/A
Forecast gearing ratio (%)N/A
SectorFood & Drink

Price performance

Relative *(2.8)(11.1)(24.5)

* % Relative to local index

Other companies in sector Show

Company news

Evolva Holding SA

Fri, 22 Nov 2013 11:19:43 GMT

Evolva to Acquire Allylix

Tue, 18 Nov 2014 06:01:29 GMT

BRIEF-Evolva announces major restructuring for next phase of its development‍​

Wed, 30 Aug 2017 06:00:00 GMT

Evolva Holdings' (ELVAF) CEO Neil Goldsmith on Q4 2016 Results - Earnings Call ...

Fri, 31 Mar 2017 18:11:15 GMT

Evolva Aktionäre stimmen dem Antrag an der AGV zu

Thu, 26 Oct 2017 18:11:15 GMT

Y/E Dec Revenue (CHFm) EBITDA (CHFm) PBT (CHFm) EPS (CHFc) P/E (x) P/CF (x)
2015A 13.4 (30.3) (32.1) (8.0) N/A N/A
2016A 9.5 (34.0) (36.0) (7.8) N/A N/A
2017E N/A N/A N/A N/A N/A N/A
2018E N/A N/A N/A N/A N/A N/A

Last updated on 23/10/2017

Latest research

Transformation evolving

Update | Food & Drink | 17/08/2017

Agreement reached

Outlook | Food & Drink | 09/05/2017

Headroom improves

Update | Food & Drink | 16/03/2017

A cloudier picture

Update | Food & Drink | 16/01/2017

On track

Update | Food & Drink | 01/09/2016

Positive stevia newsflow

Update | Food & Drink | 07/06/2016

Stevia delayed

Update | Food & Drink | 06/04/2016

Tastes good

Outlook | Food & Drink | 15/01/2016

Getting sweeter

QuickView | Food & Drink | 19/11/2015

Rights issue supports stevia JV

Update | Food & Drink | 07/09/2015

Manufacturing a sweeter future

Update | Pharmaceutical & healthcare | 18/05/2015

Daily comment

Institutional Comment | Pharmaceutical & healthcare | 11/02/2015

Investment summary

Evolva has an innovative fermentation platform focused on developing new production methods for nutritional and consumer health products, which removes supply chain issues for existing natural ingredients. Evolva's key programme for stevia sweeteners is partnered with Cargill and we expect launch during 2018. Evolva also has projects for resveratrol, nootkatone, valencene (all on the market). Simon Waddington (previously COO) recently took over as CEO and has undertaken an operational review. As a result, Evolva will consolidate its sites, centralising R&D at its Swiss HQ, and overall headcount will shrink from c 180 to c 100, significantly reducing its operating expenses. A CHF21m private placement has been completed and the company has announced its intention to raise a further CHF60m through a discounted rights issue.

Last updated on 02/11/2017

Industry outlook

Food and health ingredients continue to be in the sweet spot as consumers demand healthier products with cleaner labels without compromising on taste or convenience. Evolva's fermentation platform aims to deliver these benefits while reducing production costs.

Last updated on 02/11/2017

Key management

Gerard Hoetmer, Chairman
Simon Waddington, CEO
Oliver Walker, CFO

Company address

Duggingerstrasse. 23
+41 61 485 2000
View website